Academic Journal
Q1Current Opinion in Immunology
About Current Opinion in Immunology
Current Opinion in Immunology is a scholarly journal published by Elsevier Ltd. SCImago 2025 lists it in Q1, with an SJR of 3.01 and H-index of 218.
Coverage: 1988-2026. Research categories: Immunology (Q1); Immunology and Allergy (Q1).
Source-backed journal facts
Topics in published research
Immune Cell Function and Interaction; T-cell and B-cell Immunology; Immunotherapy and Immune Responses; Immune Response and Inflammation; Monoclonal and Polyclonal Antibodies Research; Human auditory perception and evaluation.
OpenAlex classifies topics from published works. These topics are not the publisher’s official aims and scope.
Reported open-access list prices
4,410.00 USD; 4,130.00 EUR; 3,530.00 GBP; 546,970.00 JPY
APC list prices reported by OpenAlex, which obtains this information from DOAJ. Confirm current charges, taxes, waivers and eligibility with the publisher; this is not a fee quotation.
Source: OpenAlex source record. Retrieved 2026-10-03. Source record updated 2026-10-02. OpenAlex metrics are different from SCImago metrics and the Clarivate Journal Impact Factor.
Journal Metrics
Quartile, SJR and the listed SCImago H-index use the 2025 imported SCImago dataset. A quartile may vary by subject category. Values without a source or reporting year are unverified historical entries. Verify the current Journal Impact Factor with Clarivate or the publisher before using it.
Aims & Scope
The publisher’s official aims and scope have not yet been verified for this profile. Use the journal website to check subject fit and accepted article types before submitting.
Recent Research Articles
Latest publications matched automatically by ISSN.
Corrigendum to “Use of synthetic data, a novel paradigm for immunopathology” [Curr Opin Immunol 2026;100:102753]
Antonio Tonutti, Saverio D'Amico, Suraj Timilsina, Merrill Eric Gershwin et al.
2026-12 · DOI: 10.1016/j.coi.2026.102837Complement inhibition in pediatric ANCA-associated vasculitis
Provini Chiara, Minoia Francesca, Antonio Mastrangelo, Rossano Martina et al.
2026-12 · DOI: 10.1016/j.coi.2026.102839Advancing evidence generation in pediatric rheumatology beyond traditional randomized clinical trials: the potential of innovative designs
Alessandra Alongi, Giulia Risca, Saverio La Bella, Nicolino Ruperto et al.
2026-12 · DOI: 10.1016/j.coi.2026.102841A systematic review of juvenile dermatomyositis complicated by macrophage activation syndrome
Martina Rossano, Francesco Baldo, Pasquale Vaienna, Stefano Lanni et al.
2026-12 · DOI: 10.1016/j.coi.2026.102834Cellular stress leading to epithelial cell dysfunction in Sjögren’s syndrome
María-José Barrera, Isabel Castro, María-Julieta González
2026-12 · DOI: 10.1016/j.coi.2026.102838Editorial overview: Editorial introduction — Anti-phospholipid antibody syndrome (2025)
Pier Luigi Meroni
2026-12 · DOI: 10.1016/j.coi.2026.102850Towards personalized treatment in juvenile idiopathic arthritis: moving beyond the trial-and-error strategy
Achille Marino, Marco Pandolfi, Maria Giovanna Lommano, Stefania Costi et al.
2026-12 · DOI: 10.1016/j.coi.2026.102840Clinical relevance of antiphosphatidylserine/prothrombin antibodies in antiphospholipid syndrome
Maria Laura Bertolaccini, Giovanni Sanna
2026-12 · DOI: 10.1016/j.coi.2026.102842Editorial overview: Immunity in place and time
Marco De Giovanni, Matteo Iannacone
2026-12 · DOI: 10.1016/j.coi.2026.102851Autoimmune diseases: distinct disorders or diverse manifestations of a common pathogenic process?
Haralampos M Moutsopoulos
2026-12 · DOI: 10.1016/j.coi.2026.102852The role of artificial intelligence in clinical trials in adult and pediatric rheumatology
Saverio La Bella, Ana Isabel Rebollo-Giménez, Alessandra Alongi, Giulia Capitoli et al.
2026-10 · DOI: 10.1016/j.coi.2026.102818Human endogenous retroviruses leading to autoimmune diseases
María J Mercado-Celin, Marcela Patiño-Arboleda, Lady J Rios-Serna, Maria A Bedoya-Duque et al.
2026-10 · DOI: 10.1016/j.coi.2026.102828Spatiotemporal dynamics of intestinal immune cells
Michela Frascoli, Silvia Galván Peña
2026-10 · DOI: 10.1016/j.coi.2026.102836GATA2 deficiency: enhancer deregulation, immune surveillance failure, and clonal evolution
Samuele Roncareggi, Francesco Saettini
2026-10 · DOI: 10.1016/j.coi.2026.102817Cure for psoriasis — a prospective outlook
Siba P Raychaudhuri, Smriti K Raychaudhuri, Disha Chakraborty
2026-10 · DOI: 10.1016/j.coi.2026.102820Editorial Board
2026-10 · DOI: 10.1016/s0952-7915(26)00123-8The epithelial cell in Sjögren’s syndrome: from passive target to orchestrator of autoimmune reactivity
Haralampos M Moutsopoulos
2026-10 · DOI: 10.1016/j.coi.2026.102815Mapping antibody sequences and effector functions across spatial niches
Sonia Corral, María José Pino, Camilla Engblom
2026-10 · DOI: 10.1016/j.coi.2026.102816Recurrent pericarditis in children: evidence, controversies, and emerging perspectives
Angela Mauro, Paola Baldassarre, Marianna Zicoia, Emanuele Bizzi et al.
2026-10 · DOI: 10.1016/j.coi.2026.102833Beyond randomized clinical trials in pediatric rheumatology: exploring the potential of target trial emulation
Alessandra Alongi, Carlo Alberto Scirè, Nicholas Bakewell, Suzanne M Cadarette et al.
2026-10 · DOI: 10.1016/j.coi.2026.102832Reviews
Community Reviews
Version History
September 15, 2026 at 11:45 am
September 15, 2026